NoTube: I-gel vs. Endotracheal Intubation for Laparoscopic Gynaecological Procedures

Sponsor
Universitair Ziekenhuis Brussel (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05782517
Collaborator
(none)
120
2
19.6

Study Details

Study Description

Brief Summary

The goal of this interventional study is to compare the I-gel laryngeal mask, a type of supraglottic airway device (SGA), with endotracheal intubation in terms of safety, ease of use and adverse side effects for patients during gynecologic laparoscopic procedures at the Brussels Fertility Center in Brussels, Belgium.

Condition or Disease Intervention/Treatment Phase
  • Device: Supraglottic Airway Device
  • Device: Endotracheal Tube
N/A

Detailed Description

The NoTube study aims to compare an I-gel laryngeal mask with an endotracheal tube (ETT) during gynaecological keyhole surgery (laparoscopy) as part of a fertility trajectory.

Laparoscopy requires general anaesthesia. During this general anaesthesia, the airway is secured. Classically, this is done with an endotracheal tube. This is a hollow tube between the vocal cords (in the trachea) through which the anaesthetist can support the patient's breathing during the procedure. This procedure is also called intubation. A muscle relaxant is given to make the placement of an endotracheal tube easier. Placing an endotracheal tube during laparoscopic procedures is still considered the 'gold standard'. The lungs are protected from the aspiration of stomach contents. The principal risks of intubation are tissue damage (e.g., to the lips and trachea), sore throat and damage to tooth elements.

An alternative to an endotracheal tube is a laryngeal mask. A laryngeal mask is sometimes called a 'supraglottis device' because it is inserted above the vocal cords (glottis). A laryngeal mask is generally easier to insert, no muscle relaxation is required, and there is also less risk of sore throat and less chance of tooth damage. Since the laryngeal mask does not pass through the vocal cords, there is less protection against aspiration of stomach contents.

With the arrival of newer laryngeal masks (e.g. the I-gel laryngeal mask), they are increasingly used as an alternative to an endotracheal tube during short, laparoscopic procedures. From initial studies, a laryngeal mask appears to be as effective as an endotracheal tube, with fewer side effects, such as a sore throat. Initial investigations suggest no higher risk of aspiration of gastric contents. However, there are no studies yet comparing the use of an I-gel with an endotracheal tube during short laparoscopic procedures in the context of a fertility trajectory where the whole population (i.e., patients with a BMI higher than 35kg/m²) can participate in the study.

This study will assign patients to either the endotracheal or the I-gel group. The anaesthetic during the procedure is the same in the two groups. In the endotracheal group, an additional muscle relaxant will be given. After the procedure, the patient answers some questions about possible discomforts (e.g. sore throat, hoarseness...). The patient also completes a similar questionnaire on the first day after surgery. On day three after surgery, a study officer calls the patient to review some questions again. Finally, the patient receives a final questionnaire at the end of sick leave.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
I-gel Laryngeal Mask Versus Endotracheal Intubation for Laparoscopic Gynaecological Procedures (NoTube Study)
Anticipated Study Start Date :
Apr 15, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: I-gel

Device: Supraglottic Airway Device
Placement of an I-gel Supraglottic Airway Device.
Other Names:
  • I-gel
  • Laryngeal Mask
  • Active Comparator: Endotracheal Tube

    Device: Endotracheal Tube
    Placement of an Endotracheal Tube.
    Other Names:
  • Portex Tracheal Tube
  • ETT
  • Outcome Measures

    Primary Outcome Measures

    1. Leak fraction [Thirty seconds after placement of the airway device, 30 seconds after completing insufflation of the abdomen, 30 seconds after positioning the patient in 30° Trendelenburg, every 10 minutes Trendelenburg, and 30 seconds after closing the fascia.]

      The leak fraction is defined as the leak volume divided by the inspired tidal volume. The leak volume is the difference between the inspired and expired tidal volumes.

    Secondary Outcome Measures

    1. Number of attempts for placement of the airway device [Immediately after placement of the airway device.]

      A maximum of three tries is attempted before converting to a different technique.

    2. Total induction time [Immediately after completion of the first capnography square waveform.]

      Time from when the palpebral reflex of the patient is abolished until the appearance of the first capnography square waveform.

    3. Number of manipulations of the airway device [During surgery]

      The number of times the anaesthesiologist manipulates the airway device to ensure adequate ventilation.

    4. Blood staining on the airway device [Immediately after removing the airway device]

      It is noted whether there is blood staining of the airway device.

    5. The presence of nausea and vomiting [30 minutes after removal of the airway device, 1 hour after removal and 2 hours after removal.]

      Grading of nausea severity: 0: No nausea 1: Mild nausea, not requesting pharmacological rescue 2: Moderate nausea, requesting pharmacological rescue 3: Severe nausea resistant to pharmacological treatment Grading of Vomiting severity: 0: No vomiting 1: Mild Vomiting, not requesting pharmacological rescue 2: Moderate vomiting, requesting pharmacological rescue 3: Severe vomiting, resistant to pharmacological treatment

    6. The presence of dysphagia [30 minutes after removal of the airway device, 1 hour after removal and 2 hours after removal]

      Presence of dysphagia: 0: no dysphagia 1: Mild, only rare episodes, not considered a significant problem 2: Moderate, occasional difficulty swallowing specific foods (e.g. steak) 3: Severe, frequent difficulties swallowing the majority of food

    7. The presence of hoarseness [30 minutes after removal of the airway device, 1 hour after removal and 2 hours after removal]

      Presence of hoarseness: 0: No hoarseness present 1: Hoarseness noted by the patient 2: Mild readily apparent hoarseness of voice 3: Severe readily apparent hoarseness of voice

    8. The presence of respiratory complications [30 minutes after removal of the airway device, 1 hour after removal and 2 hours after removal]

      Grade 0: no respiratory complications Grade 1: Any deviation from normal postoperative course without the need of pharmacological treatment or surgical, endoscopic and radiological intervention. Grade 2: Requiring specific pharmacological treatment. For example, pneumonia requiring antibiotics. Grade 3: Requiring surgical, endoscopic or radiological intervention. Grade 4: Life-threatening condition requiring intensive care unit (ICU) admission

    9. Overall satisfaction [Postoperative day one, day three and either day seven (for diagnostic laparoscopies) or day 14 (for all other surgeries).]

      An online questionnaire completed by the patient. Pain intensity will be recorded using a visual analogue scale and measuring the distance between the 'no pain' point (0 millimeters) and the patient's mark. A longer distance equals more intense pain.

    10. Quality of the surgical working conditions [During surgery]

      The surgeon is asked every 10 minutes to asses the quality of the surgical conditions using the Leiden Surgical Rating Scale (L-SRS). The L-SRS is a Likert scale ranging from 1 to 5 where 1 indicates extremely poor conditions, 2 poor conditions, 3 acceptable conditions, 4, good conditions and 5 optimal conditions

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • The expected duration of the procedure does not exceed 2 hours

    • Agreeing to participate in the study

    Exclusion Criteria:
    • The expected duration of the procedure is longer than 2 hours

    • The patient suffers from restricted mouth opening, trismus, recent oral trauma or oral abscesses

    • The patient has a BMI of more than 40 kg/m²

    • The patient is known to have gastroparesis or another risk factor that would prevent you from being sober during the procedure

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Universitair Ziekenhuis Brussel

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Universitair Ziekenhuis Brussel
    ClinicalTrials.gov Identifier:
    NCT05782517
    Other Study ID Numbers:
    • 22228NoTube
    First Posted:
    Mar 23, 2023
    Last Update Posted:
    Mar 23, 2023
    Last Verified:
    Nov 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Universitair Ziekenhuis Brussel

    Study Results

    No Results Posted as of Mar 23, 2023